Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men

NCT01765179 is registered in ClinicalTrials.gov with Clarus Therapeutics, Inc. as lead sponsor.

NCT NCT01765179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01765179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Lead sponsor
Clarus Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
July 31, 2013
Enrollment
144 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

male hypogonadism